N. Bulut

发表

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?

A. Ulaş, N. Avcı, T. Kos, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Multimodality treatment in the management of anorectal melanoma: a case report and review of the literature.

O. Dizdar, I. Çelik, U. Tapan, 2011, The Eurasian journal of medicine.

Favorable results of patients with pT1a, b, c, lymph node-negative early breast cancer in the long interval

K. Altundag, A. Ulaş, N. Bulut, 2019, Journal of cancer research and therapeutics.

Retrospective Analysis of Vitamin D Levels in Patients with Chronic Renal Failure, Obesity, and Cancer

N. Bulut, M. C. Taskapan, Fatma Ölmez Budak, 2021, Ege Tıp Bilimleri Dergisi.

Albumin-Bound Paclitaxel, ABI-007 May Show Better Efficacy than Paclitaxel in Basal-Like Breast Cancers: Association Between Caveolin-1 Expression and ABI-007

H. Harputluoglu, K. Altundag, O. Dizdar, 2006, Breast Cancer Research and Treatment.

Excellent clinical outcome of triple-negative breast cancer in younger and older women.

N. Bulut, K. Altundağ, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.

H. Harputluoglu, Y. Ozisik, O. Dizdar, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute abdomen due to anthrax

A. Tekin, N. Bulut, T. Ünal, 1997, The British journal of surgery.

The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern.

H. Harputluoglu, N. Bulut, E. Sarı, 2007, American journal of surgery.

Pathological characteristics of very young (< or = 30 years) breast cancer patients: a single-institution experience from Turkey.

O. Dizdar, S. Aksoy, N. Bulut, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Mitochondrial neurogastrointestinal encephalomyopathy Mitokondrial nörogastrointestinal ensafalomyopati

H. Bektaş, N. Bulut, M. Oztekin, 2005 .

Mitochondrial neurogastrointestinal encephalomyopathy Mitokondrial nörogastrointestinal ensafalomyopati

N. Bulut, Gülay Ulusal, Ezgi COfiKUN, 2005 .

Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.

A. Ulaş, N. Avcı, T. Kos, 2015, Asian Pacific journal of cancer prevention : APJCP.

Diffuse Large B-Cell Lymphoma Involvement in Two Different Localizations: A Case Report

N. Bulut, I. Ozaydin, Hilal Serap Arslan, 2019, The Surgery Journal.

Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer's disease.

M. Ozen, N. Bulut, M. Tezcan, 2007, Medical hypotheses.

Surgical Approach to Anorectal Melanoma with PET-CT Staging: A Case Report

N. Bulut, Burçak Yılmaz, O. F. Atay, 2017, The Surgery Journal.

Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines

O. Dizdar, N. Bulut, D. Dede, 2007, Breast Cancer Research and Treatment.

Misleading 18FDG-PET/CT finding caused by chronic HIV infection in a patient with gastric carcinoma: a case report

N. Bulut, Burçak Yılmaz, 2018, International journal of STD & AIDS.

Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?

N. Bulut, E. Sarı, D. Dede, 2007, Breast Cancer Research and Treatment.

A Case of Ruptured Pulmonary Hydatid Cyst of the Liver and Review of the Literature

N. Bulut, Sevinç Dağıstanlı, 2017, Case Reports in Radiology.

Histopathological Characteristics: Clinical Course of Breast Cancer Subtypes Depending on the ER(+) (−)/PR(+) (−) Receptor Status

N. Bulut, 2017 .

Aromatase inhibitor-associated arthralgia: Prevalence, clinical and serum parameters among Turkish postmenopausal breast cancer patients

H. Harputluoglu, Y. Ozisik, O. Dizdar, 2008 .

Response to taxanes in triple negative breast cancer

S. Kılıçkap, N. Bulut, E. Sarı, 2008, Cancer Chemotherapy and Pharmacology.

Does estrogen receptor determination affect prognosis in early stage breast cancers?

N. Bulut, K. Altundağ, 2015, International journal of clinical and experimental medicine.

Role of trastuzumab in patients with brain metastases from Her2 positive breast cancer

H. Harputluoglu, O. Dizdar, N. Bulut, 2007, Journal of Neuro-Oncology.

Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer.

O. Dizdar, N. Bulut, K. Altundağ, 2008, Breast.

Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

O. Dizdar, I. Gullu, S. Aksoy, 2011, Medical oncology.

The extent of agreement between frozen and paraffin block data from axillary samples in patients with early-stage breast cancer.

N. Bulut, Suleyman Sonmez, Sevinc Dagistanli, 2022, Annals of diagnostic pathology.

Ribociclib-induced visual hallucination in a patient with metastatic breast cancer

N. Bulut, G. Erdem, S. Demirer, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.